In vitro inhibition of expression of virulence genes responsible for colonization and systemic spread of enteric pathogens using Bifidobacterium bifidum secreted molecules

International Journal of Food Microbiology

Volumn 156, Issue 3, 2012, Pages 255-263

  Bayoumi, Mohamed A ^a,b   Griffiths, Mansel W ^b  

^a Zagazig University   (Egypt)

^b UNIVERSITY OF GUELPH   (Canada)

Author keywords

Bifidobacterium bifidum; E. coli; Probiotic; Salmonella; Virulence

Indexed keywords

PROBIOTIC AGENT; VIRULENCE FACTOR;

ARTICLE; BACTERIAL COLONIZATION; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIAL SURVIVAL; BACTERIAL VIRULENCE; BIFIDOBACTERIUM BIFIDUM; CELL FREE SYSTEM; DOWN REGULATION; ENTEROHEMORRHAGIC ESCHERICHIA COLI; EUKARYOTIC CELL; FOOD POISONING; GEL PERMEATION CHROMATOGRAPHY; GENE CONSTRUCT; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; MACROPHAGE; NONHUMAN; PATHOGENICITY; REGULATOR GENE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SALMONELLA ENTERICA; SALMONELLA ENTERICA SEROVAR TYPHIMURIUM;

BIFIDOBACTERIUM; DOWN-REGULATION; ESCHERICHIA COLI; MACROPHAGES; POLYMERASE CHAIN REACTION; PROBIOTICS; SALMONELLA ENTERICA; SALMONELLA INFECTIONS; VIRULENCE; VIRULENCE FACTORS;

BIFIDOBACTERIUM BIFIDUM; ESCHERICHIA COLI; EUKARYOTA; SALMONELLA; SALMONELLA ENTERICA SUBSP. ENTERICA SEROVAR TYPHIMURIUM;

EID: 84860992684     PISSN: 01681605     EISSN: 18793460     Source Type: Journal    
DOI: 10.1016/j.ijfoodmicro.2012.03.034     Document Type: Article

References (64)

1. Akabar S., Schechter L.M., Lostroh C.P., Lee C.A. AraC/XylS family members, HilD and HilC, directly activate virulence gene expression independently of HilA in Salmonella typhimurium. Molecular Microbiology 2003, 47:715-728.
2. Altier C., Suyemoto M., Ruiz A.I., Burnham K.D., Maurer R. Characterization of two novel regulatory genes affecting Salmonella invasion gene expression. Molecular Microbiology 2000, 35:635-646.
3. Bajaj V., Hwang C., Lee C.A. HilA is a novel Ompr/ToxR family member that activates the expression of Salmonella typhimurium invasion genes. Molecular Microbiology 1995, 18:715-727.
4. Bayoumi M.A., Griffiths M.W. Probiotics down-regulate genes in Salmonella enterica serovar Typhimurium pathogenicity islands I and II. Journal of Food Protection 2010, 73(3):452-460.
5. Biavati B., Vescovo M., Torriani S., Bottazzi V. Bifidobacteria: history, ecology, physiology and applications. Annals of Microbiology 2000, 50:117-131.
6. Bispham J., Tripathi B.N., Watson P.R., Wallis T.S. Salmonella pathogenicity island 2 influences both systemic salmonellosis and Salmonella-induced enteritis in calves. Infection and Immunity 2001, 69:367-377.
7. Boerlin P., Mcewen S.A., Boerlin-petzold F., Wilson J.B., Johnson R.P., Gyles C.L. Associations between virulence factors of Shiga toxin-producing Escherichia coli and disease in humans. Journal of Clinical Microbiology 1999, 37:497-503.
8. Cheikhyoussef A., Pogori N., Chen H.Q., Tian F.W., Chen W., Tang J. Antimicrobial activity and partial characterization of bacteriocin-like inhibitory substances (BLIS) produced by Bifidobacterium infantis BCRC 14602. Food Control 2009, 20:553-559.
9. Chiu C.-H., T'ang P., Chu C., Hu S., Yu Q.J., Chou Y.-Y., Wang H.-S., Lee Y.S. The genome sequence of Salmonella enterica serovar Choleraesuis, a highly invasive and resistant zoonotic pathogen. Nucleic Acids Research 2005, 33:1690-1698.
10. Collado M.C., Hernandez M., Sanz Y. Production of bacteriocin-like inhibitory compounds by human fecal Bifidobacterium strains. Journal of Food Protection 2005, 68:1034-1040.
11. De Vuyst L., Avonts L., Makras L. Chapter 17: probiotics, prebiotics and gut health. Functional Foods, Ageing and Degenerative Disease 2004, 416-482. Woodhead Publishing Ltd, Cambridge, UK. 1st ed. C. Remacle, B. Reusens (Eds.).
12. Ding W., Wang H., Griffiths M.W. Probiotics down-regulate flaA sigma28 promoter in Campylobacter jejuni. Journal of Food Protection 2005, 68(11):2295-2300.
13. Ehrbar K., Mirold S., Friebel A., Stender S., Hardt W.D. Characterization of effector proteins translocated via the SPI1 type III secretion system of Salmonella typhimurium. International Journal of Medical Microbiology 2002, 291:479-485.
14. Elliott S.J., Wainwright L.A., McDaniel T.K., Jarvis K.G., Deng Y.K., MacNamara B.P., Donnenberg M.S., Kaper J.B. The complete sequence of the locus of enterocyte effacement (LEE) from enteropathogenic E. coli E2348/69. Molecular Microbiology 1998, 28:1-4.
15. Everest P., Ketley J., Hardy S., Douce G., Khan S., Shea J., Holden D., Maskell D., Dougan G. Evaluation of Salmonella typhimurium mutants in a model of experimental gastroenteritis. Infection and Immunity 1999, 67:2815-2821.
16. Falk P.G., Hooper L.V., Midtvedt T., Gordon J.I. Creating and maintaining the gastrointestinal ecosystem: what we know and need to know from gnotobiology. Microbiology and Molecular Biology Reviews 1998, 62:1157-1170.
17. Fanaro S., Chierici R., Guerrini P., Vigi V. Intestinal microflora in early infancy: composition and development. Acta Paediatrica. Supplement 2003, 91(441):48-55.
18. Feng X., Oropeza R., Kenney L.J. Dual regulation by phospho-OmpR of ssrA/B gene expression in Salmonella pathogenicity island 2. Molecular Microbiology 2003, 48:1131-1143.
19. Gallois A., Klein J.R., Allen L.A., Jones B.D., Nauseef W.M. Salmonella pathogenicity island 2-encoded type III secretion system mediates exclusion of NADPH oxidase assembly from the phagosomal membrane. Journal of Immunology 2001, 166:5741-5748.
20. Hansen-Wester I., Hensel M. Salmonella pathogenicity islands encoding type III secretion systems. Microbes and Infection 2001, 3:549-559.
21. Hensel M., Shea J.E., Gleeson C., Jones M.D., Dalton M.D.E., Holden D.W. Simultaneous identification of bacterial virulence genes by negative selection. Science 1995, 269:400-403.
22. Hisako Y., Shida K., Matsuzaki T., Yokokura T. Immunomodulatory function of lactic acid bacteria. Antonie Van Leeuwenhoek 1999, 76:383-389.
23. Jerse A.E., Kaper J.B. The eae gene of enteropathogenic Escherichia coli encodes a 94-kilodalton membrane protein, the expression of which is influenced by the EAF plasmid. Infection and Immunity 1991, 59:4302-4309.
24. Jerse A.E., Yu J., Tall B.D., Kaper J.B. A genetic locus of enteropathogenic Escherichia coli necessary for the production of attaching and effacing lesions on tissue culture cells. Proceedings of the National Academy of Sciences of the United States of America 1990, 87:7839-7843.
25. Kaper J.B. Pathogenic Escherichia coli. International Journal of Medical Microbiology 2005, 295:355-356.
26. Lara-Villoslada F., Olivares M., Sierra S., Rodriguez J.M., Boza J., Xaus J. Beneficial effects of probiotic bacteria isolated from breast milk. British Journal of Nutrition 2007, 98:s96-s100.
27. Lavigne J.P., Blanc-Potard A.B. (Discussion) Molecular evolution of Salmonella enterica serovar Typhimurium and pathogenic Escherichia coli: from pathogenesis to therapeutics. Infection, Genetics and Evolution 2008, 8:217-226.
28. Law D. Virulence factors of Escherichia coli O157:H7 and other Shiga toxin producing E. coli. Journal of Applied Microbiology 2000, 88:729-745.
29. Leahy S.C., Higgins D.G., Fitzgerald G.F., van Sinderen D. Getting better with bifidobacteria. Journal of Applied Microbiology 2005, 98:1303-1315.
30. Lostroh C.P., Lee C.A. The Salmonella pathogenicity island-1 type III secretion system. Microbes and Infection 2001, 3:1281-1291.
31. Lostroh C.P., Bajaj V., Lee C.A. The cis requirements for transcriptional activation by HilA, a virulence determinant encoded on SPI-1. Molecular Microbiology 2000, 37:300-315.
32. Lucas R.L., Lee C.A. Roles of hilC and hilD in regulation of hilA expression in Salmonella enterica serovar Typhimurium. Journal of Bacteriology 2001, 183:2733-2745.
33. Marlovits T.C., Kubori T., Sukhan A., Thomas D.R., Galan J.E., Unger V.M. Structural insights into the assembly of the type III secretion needle complex. Science 2004, 306:1040-1042.
34. Marlovits T.C., Kubori T., Lara-Tejero M., Thomas D., Unger V.M., Galan J.E. Assembly of the inner rod determines needle length in the type III secretion injectisome. Nature 2006, 441:637-640.
35. Martin R., Langa S., Reviriego C., Jimenez E., Marin M.L., Xaus J., Fernandez L., Rodriguez J.M. Human milk is a source of lactic acid bacteria for the infant gut. Journal of Pediatrics 2003, 143:754-758.
36. Martin R., Jimenez E., Heilig H., Fernandez M., Martin L.M., Zoetendal E.G., Rodriguez J.M. Isolation of bifidobacteria from breast milk and assessment of the bifidobacterial population by PCR-denaturing gradient gel electrophoresis and quantitative real-time PCR. Applied and Environmental Microbiology 2009, 75:965-969.
37. McClelland M.K., Sanderson E., Spieth J., Clifton S.W., Latreille P., Courtney L., Porwolik S., Ali J., Dante M., Du F., Layman D., Leonard S., Nguyen C., Scott K., Holmes A., Grewald N., Mulvaney E., Ryan E., Sun H., Florea L., Miller W., Stoneking T., Nhan M., Waterston R., Wilson R.K. Complete genome sequence of Salmonella enterica serovar Typhimurium LT2. Nature 2001, 413:852-856.
38. McDaniel T.K., Jarvis K.G., Donnenberg M.S., Kaper J.B. A genetic locus of enterocyte effacement conserved among diverse enterobacterial pathogens. Proceedings of the National Academy of Sciences of the United States of America 1995, 92:1664-1668.
39. Medellin-Peña M.J., Griffiths M.W. Effect of molecules secreted by Lactobacillus acidophilus strain La-5 on Escherichia coli O157:H7 colonization. Applied and Environmental Microbiology 2009, 75(4):1165-1172.
40. Medellin-Peña M.J., Wang H., Johnson R., Anand S., Griffiths M.W. Probiotics affect virulence-related gene expression in Escherichia coli O157:H7. Applied and Environmental Microbiology 2007, 73:4259-4267.
41. Mills D.M., Bajaj V., Lee C.A. A 40kb chromosomal fragment encoding Salmonella typhimurium invasion genes is absent from the corresponding region of the Escherichia coli K-12 chromosome. Molecular Microbiology 1995, 15:749-759.
42. Ochman H., Soncini F.C., Solomon F., Groisman E.A. Identification of a pathogenicity island required for Salmonella survival in host cells. Proceedings of the National Academy of Sciences of the United States of America 1996, 93:7800-7804.
43. Parkhill J., Dougan G., James K.D., Thompson N.R., Pickard D., Wain J., Churcher C., Mungall K., Bentley S.D., Holden M.T.G., Sebaihia M., Baker S., Bashman D., Brooks K., Chillingworth T., Connerton P., Cronin A., Davis P., Davies R.M., Dowd L., White N., Farrar J., Fettwell T., Hamlin N., Haque A., Hien T.T., Holroyd S., Jagels K., Krogh A., Larsen T.S., Leather S., Moule S., O'Gaora P., Parry C., Quail M., Rutherford K., Siinmonds M., Skelton J., Stevens K., Whitehead S., Barrel B.G. Complete genome sequence of a multiple drug resistant Salmonella enterica serovar Typhi CT 18. Nature 2001, 413:848-852.
44. Phillips A.D., Frankel G. Intimin-mediated tissue specificity in enteropathogenic Escherichia coli interaction with human intestinal organ cultures. Journal of Infectious Diseases 2000, 181:1496-1500.
45. Picard C., Fioramonti J., Francois A., Robinson T., Neant F., Matuchansky C. Review article: bifidobacteria as probiotic agents physiological effects and clinical benefits. Alimentary Pharmacology & Therapeutics 2005, 22:495-512.
46. Pompei A., Cordisco L., Amaretti A., Zanoni S., Matteuzzi D., Rossi M. Folate production by bifidobacteria as a potential probiotic property. Applied and Environmental Microbiology 2007, 73:179-185.
47. Santos R.L., Zhang S., Tsolis R.M., Kingsley R.A., Adams L.G., Baumler A.J. Animal models of Salmonella infections: enteritis versus typhoid fever. Microbes and Infection 2001, 3:1335-1344.
48. Schechter L.M., Lee C.A. AraC/XylS family members, HilC and HilD, directly bind and derepress the Salmonella typhimurium hilA promoter. Molecular Microbiology 2001, 40:1289-1299.
49. Schechter L.M., Damrauer S.M., Lee C.A. Two AraC/XylS family members can independently counteract the effect of repressing sequences upstream of the hilA promoter. Molecular Microbiology 1999, 32:629-642.
50. Schmidt H.M., Hensel M. Pathogenicity islands in bacterial pathogenesis. Clinical Microbiology Reviews 2004, 17:14-56.
51. Servin A.L. Antagonistic activities of lactobacilli and bifidobacteria against microbial pathogens. FEMS Microbiology Reviews 2004, 28:405-440.
52. Sghir A., Gramet G., Suau A., Rochet V., Pochart P., DoreD́ J. Quantification of bacterial groups within the human fecal flora by oligonucleotide probe hybridization. Applied and Environmental Microbiology 2000, 66:2263-2266.
53. Shea J.E., Hensel M., Gleeson C., Holden D.W. Identification of a virulence locus encoding a second type III secretion system in Salmonella typhimurium. Proceedings of the National Academy of Sciences of the United States of America 1996, 93:2593-2597.
54. Shu Q., Lin H., Rutherfurd K.J., Fenwick S.G., Prasad J., Gopal P.K., Gill H.S. Dietary Bifidobacterium lactis (HN019) enhances resistance to oral Salmonella typhimurium infection in mice. Microbiology and Immunology 2000, 44:213-222.
55. Shu Q., Qu F., Gill H.S. Probiotic treatment using Bifidobacterium lactis HN019 reduces weanling diarrhea associated with rotavirus and Escherichia coli infection in a piglet model. Journal of Pediatric Gastroenterology and Nutrition 2001, 33:171-177.
56. Tellez A., Corredig M., Turner P.V., Morales R., Griffiths M.W. A peptidic fraction from milk fermented with Lactobacillus helveticus protects mice against Salmonella infection. International Dairy Journal 2011, 21:607-614.
57. Tuomola E.M., Ouwehanda A.C., Salminen S.J. The effect of probiotic bacteria on the adhesion of pathogens to human intestinal mucus. FEMS Immunology and Medical Microbiology 1999, 26(2):137-142.
58. Uelivon, A.H., 2006. Identification of Bifidobacterium thermophilum RBL67 isolated from baby faeces and partial purification of its bacteriocin. Ph.D. Thesis, Swiss Federal Institute of Technology, Zurich, Switzerland.
59. Vazquez-Torres A., Fang F.C. Salmonella evasion of the NADPH phagocyte oxidase. Microbes and Infection 2001, 3:1313-1320.
60. Waterman S.R., Holden D.W. Functions and effectors of the Salmonella pathogenicity island 2 type III secretion system. Cellular Microbiology 2003, 5:501-511.
61. Yamamoto S., Wada J., Katayama T., Jikimoto T., Nakamura M., Kinoshita S., Lee K., Kawabata M., Shirakawa T. Genetically modified Bifidobacterium displaying Salmonella-antigen protects mice from lethal challenge of Salmonella typhimurium in a murine typhoid fever model. Vaccine 2010, 28:6684-6691.
62. Yildirim Z., Winters D.K., Johnson M.G. Purification, amino acid sequence and mode of action of bifidocin B produced by Bifidobacterium bifidum NCFB 1454. Journal of Applied Microbiology 1999, 86:45-54.
63. Yip C.K., Kimbrough T.G., Felise H.B., Vuckovic M., Thomas N.A., Pfuetzner R.A., Frey E.A., Finlay B.B., Miller S.I., Strynadka N.C. Structural characterization of the molecular platform for type III secretion system assembly. Nature 2005, 435:702-707.
64. Zhang W.L., Kohler B., Oswald E., Beutin L., Karch H., Morabito S., Caprioli A., Suerbaum S., Schmidt H. Genetic diversity of intimin genes of attaching and effacing Escherichia coli strains. Journal of Clinical Microbiology 2002, 40:4486-4492.